# A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours

> **NCT03009214** · PHASE1 · COMPLETED · sponsor: **amcure GmbH** · enrollment: 55 (actual)

## Conditions studied

- Malignant Solid Tumor

## Interventions

- **DRUG:** AMC303

## Key facts

- **NCT ID:** NCT03009214
- **Lead sponsor:** amcure GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2020-07-28
- **Final completion:** 2021-05-07
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2021-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009214, "A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03009214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*